Alglucerase
Overview
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Alglucerase's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| | | | Alglucerase injection is administered by intravenous infusion over 1-2 hours. Dosage should be individualized for each patient. Initial dosage may be as little as 2.5 units/kg of body weight 3 times a week up to as much as 60 units/kg administered as frequently as once a week or as infrequently as every 4 weeks. 60 units/kg every 2 weeks is the dose for which the most data are available |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Alglucerase is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Alglucerase is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Alglucerase
Back to top
Previous Drug Generic - Next Drug Generic